Crispr Therapeutics Stock Forecast

Hold candidate since Jun 10, 2026 Gain 0.73%

The CRISPR Therapeutics stock price fell by -0.86% on the last day (Friday, 12th Jun 2026) from $50.23 to $49.80. During the last trading day the stock fluctuated 3.09% from a day low at $49.71 to a day high of $51.25. The price has fallen in 7 of the last 10 days and is down by -11.36% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -363 thousand shares and in total, 1 million shares were bought and sold for approximately $57.22 million.

The stock lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $48.68 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 7.17% during the next 3 months and, with a 90% probability hold a price between $52.17 and $64.83 at the end of this 3-month period.

CRSP Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The CRISPR Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $51.62 and $51.87. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -12.55%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for CRISPR Therapeutics stock

CRISPR Therapeutics finds support from accumulated volume at $48.79 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.54 between high and low, or 3.09%. For the last week, the stock has had daily average volatility of 4.79%.

Our recommended stop-loss: $46.80 (-6.02%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (CRSP) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect CRISPR Therapeutics AG to open at $50.25, and during the day (based on 14 day Average True Range), to move between $48.38 and $51.22, which gives a possible trading interval of +/-$2.84 (+/-5.86%) up or down from last closing price. If CRISPR Therapeutics AG takes out the full calculated possible swing range there will be an estimated 5.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $48.79 (2.04%) than the resistance at $52.38 (5.18%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is CRISPR Therapeutics AG stock A Buy?

CRISPR Therapeutics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.590 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $50.25 ( 0.91%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk